Remedy Meds vs. SkinnyRx: prices, fine print, and the honest verdict

Tirzepatide pricing

On tirzepatide, SkinnyRx is the cheaper program at $299 a month all-in versus Remedy Meds's $399 — a gap of $100 a month, $1,200 a year, at the 10 mg maintenance basis. Remedy Meds: $399 a month all-in at the 10 mg maintenance basis, flat at every dose from 2.5 to 15 mg, no membership fee. SkinnyRx: $299 a month all-in at the 10 mg maintenance basis, flat at every dose from 2.5 to 15 mg, no membership fee.

Semaglutide pricing

On semaglutide, SkinnyRx wins at $199 versus $299 all-in — $100/mo apart. Remedy Meds: Semaglutide runs $299 a month all-in. SkinnyRx: Semaglutide runs $199 a month all-in.

Transparency

Remedy Meds: Third-party-reported (verified 2026-08-05); dispensing pharmacy not publicly named. SkinnyRx: Source-verified (verified 2026-08-05); dispensing pharmacy not publicly named. In this market, a named pharmacy and a dated, source-verified price are worth real money — they are what let you check the claim instead of trusting it.

Commitment & cancellation

Remedy Meds: unknown; not published. SkinnyRx: none; no membership on compounded programs.

The gap, compounded over time

A $100/month difference sounds decidable by coin flip until it's annualized: choosing Remedy Meds over SkinnyRx at the standing rates costs an extra one month, $100; six months, $600; a year, $1,200; two years of maintenance, $2,400. Every figure is the all-in maintenance basis; the arithmetic reruns from the dataset.

The 24-month ledger

Zoom to the horizon that matters for a chronic-use drug — 24 months — and Remedy Meds bills $9,576 and SkinnyRx $7,176, a spread of $2,400 for the same molecule at the same 10 mg basis. Reference rails for the same 24 months: $5,160 at the verified floor, $10,776 on brand Zepbound at maintenance, $8,376 on Wegovy flat.

Two ladders, side by side

The 2.5-to-10 mg climb is the honest stress test: Remedy Meds holds $399 on every rung (four-month titration: exactly $1,596); SkinnyRx holds $299 on every rung (four-month titration: exactly $1,196). A flat ladder makes dose decisions purely clinical; a scaled one attaches an invoice to every escalation — including the post-plateau bump from 10 to 12.5 mg that many patients eventually face. Full framework: the titration cost guide.

Three buyers, two invoices

The month-one starter pays $399 at Remedy Meds versus $299 at SkinnyRx for the 2.5 mg rung — an early edge that holds once the ladder climbs. The settled 10 mg maintainer — the buyer our basis is built for — pays $3,588/year at SkinnyRx against $4,788 at the other: $1,200 of annual daylight for the same molecule and dose.

The semaglutide board

SkinnyRx takes the semaglutide board too at $199 versus $299 all-in — a $100/month, $1,200/year spread. Both sit against a verified field floor of $133 and Wegovy's flat $349 brand rate; dual-molecule pricing also sets each program's internal switch cost when a plateau raises the tirzepatide question.

The five normalizations, applied to this pair

1 · All-in, not advertised. Remedy Meds's ranked figure is $399, with no membership to add; SkinnyRx's ranked figure is $299, with no membership to add. 2 · Maintenance basis. Remedy Meds is dose-flat, so its entry and 10 mg figures coincide; SkinnyRx is dose-flat, so its entry and 10 mg figures coincide. 3 · Terms separated. Remedy Meds: standing $399, no prepaid tier; SkinnyRx: standing $299, no prepaid tier — standing rates rank, prepaid effectives are labeled beside them. 4 · Evidence tiered. Remedy Meds: third-party-reported, read 2026-08-05; SkinnyRx: source-verified, read 2026-08-05. 5 · Pharmacy weighed. Remedy Meds names no pharmacy; SkinnyRx names no pharmacy — in a pharmacy-variance market, disclosure is a scored asset. Run the same five on any roundup you read and most published “cheapest” lists reorder themselves.

Fine print, itemized

Remedy Meds: no membership — the medication figure is the billed figure; not published; commitment: unknown. SkinnyRx: no membership — the medication figure is the billed figure; no membership on compounded programs; commitment: none. The pattern to police on both sides is the same: memberships that outlive the medication order, renewal-relative cancellation deadlines, and prepaid terms whose refund language matters more than their discount in a year of live litigation. Cancel in writing; screenshot everything.

Transparency, audited

Remedy Meds carries third-party-reported pricing (last read 2026-08-05); its dispensing pharmacy is not publicly named, so the five pharmacy questions (name, 503A/503B status, state licensure, certificate of analysis, formulation) are your pre-purchase homework. SkinnyRx carries source-verified pricing (last read 2026-08-05); its dispensing pharmacy is not publicly named, so the five pharmacy questions (name, 503A/503B status, state licensure, certificate of analysis, formulation) are your pre-purchase homework. Our weighting is unapologetic: in a market of identical molecule names, a dated source-verified price and a named pharmacy are the two claims a buyer can actually check, and they carry 25 of 100 formula points between them — the methodology shows the math, and the pharmacy guide decodes every answer the five questions can return.

Switching between them

Neither program locks the door: a Remedy Meds-to-SkinnyRx move is a new intake, a new prescription at the new pharmacy, and a written cancellation at the old shop — typically a one-to-two-week overlap if you time the last fill. What does not move with you: prepaid months, membership balances, and any dose paperwork, so re-state your current rung clearly at the new intake.

Refills, shipping, and the week-to-week reality

Past the pricing page, the operational facts are what a subscriber lives with: Remedy Meds: shipping included; consultation included. SkinnyRx: shipping included; consultation included; async visit model. Cold-chain shipments run 3–7 days across the market; the recurring failure modes are refill-timing gaps and pharmacy backlogs, so whichever program wins here, order refills a week early and confirm the pharmacy’s current turnaround at intake.

Who should pick which

Pick Remedy Meds if its published terms happen to fit your state, format, or timing. Pick SkinnyRx if the $100/month tirzepatide saving is the point; the semaglutide line is cheaper here. Neither answer is universal — which is the argument for choosing from data with dates on it rather than from whichever ad loaded first.

If neither one fits

Two programs never exhaust the market — the nearest substitutes on the verified board are Henry Meds at $349 (flat, no membership); TrimRx at $349 (flat, no membership); Lavender Sky Health at $352 (dose-scaled, $25 membership included) — or skip straight to the rankings page, where every standard “cheapest / best / no-commitment” question is answered in one sourced sentence.

The brand benchmark both must beat

Neither program exists in a vacuum: FDA-approved Zepbound sits at $449/month at maintenance (LillyDirect or retail KwikPens, ~$350 on TrumpRx, ~$50 for newly eligible Medicare patients), and Wegovy at a flat $349. The cheaper of these two compounded options saves $1,800/year against the Zepbound benchmark — the number that has to justify accepting a not-FDA-reviewed product, per the full trade analysis. When a compounded quote drifts above ~$350, this benchmark starts winning the argument on its own.

The verdict

On the numbers alone, SkinnyRx is the cheaper tirzepatide program by $100/mo and it doesn't trade that price for opacity. Both records, with dates and sources, live in the pricing database.